CS logo
small CS logo
Ibaraki Kenritsu Chuo Hospital & Cancer Center

Nishi Ibarakigun Tomobemachi Koibuchi 6528, Ibaraki, Japan
笠間市の公立病院

About Ibaraki Kenritsu Chuo Hospital & Cancer Center


茨城県立中央病院は、茨城県笠間市にある医療機関。茨城県が運営する病院である。
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Ibaraki Kenritsu Chuo Hospital & Cancer Center


During the past decade, Ibaraki Kenritsu Chuo Hospital & Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Ibaraki Kenritsu Chuo Hospital & Cancer Center" #1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 6 trials as a collaborator, "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 2 trials as a collaborator, "Taiho Pharmaceutical Co., Ltd." with 1 trials as a collaborator and "Yakult Honsha Co., LTD" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

Clinical Trials Conditions at Ibaraki Kenritsu Chuo Hospital & Cancer Center


According to Clinical.Site data, the most researched conditions in "Ibaraki Kenritsu Chuo Hospital & Cancer Center" are "Alzheimer Disease" (1 trials), "Alzheimer's Disease" (1 trials), "Colorectal Neoplasms" (1 trials), "Gastric Cancer" (1 trials) and "Malignant Pericardial Effusion" (1 trials). Many other conditions were trialed in "Ibaraki Kenritsu Chuo Hospital & Cancer Center" in a lesser frequency.

Clinical Trials Intervention Types at Ibaraki Kenritsu Chuo Hospital & Cancer Center


Most popular intervention types in "Ibaraki Kenritsu Chuo Hospital & Cancer Center" are "Drug" (5 trials), "Biological" (2 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "ACC-001" (2 trials), "QS-21" (2 trials), "5FU+l-leucovorin" (1 trials), "Etoposide and cisplatin after chemoradiotherapy" (1 trials) and "Irinotecan and cisplatin after chemoradiotherapy" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Ibaraki Kenritsu Chuo Hospital & Cancer Center


The vast majority of trials in "Ibaraki Kenritsu Chuo Hospital & Cancer Center" are 8 trials for "All" genders.

Clinical Trials Status at Ibaraki Kenritsu Chuo Hospital & Cancer Center


Currently, there are NaN active trials in "Ibaraki Kenritsu Chuo Hospital & Cancer Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Ibaraki Kenritsu Chuo Hospital & Cancer Center, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Ibaraki Kenritsu Chuo Hospital & Cancer Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".